//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
A Phase 3 clinical study from Italfarmaco is now enrolling adults with polycythemia vera (PV) to evaluate an investigational treatment.  A study doctor can help determine eligibility. Participation is voluntary.  Learn more: https://f.mtr.cool/ivmlznwcpb
Dana shares her journey with PV — diagnosis, challenges, and learning to advocate for herself. Watch and explore more: https://f.mtr.cool/usmmcielyd
We recently rolled out a number of updates and improvements to the MPN PROGRESSion Registry® system to make it more user-friendly. Enrolled? Log into your portal to explore what’s new. Want to sign up? Enroll today:
Setting new standards in MPN clinical trials will move faster if we learn from what’s already working. At the 2026 MPN Roundtable™, we brought the #MPN community together to learn from progress in other malignancies and turn insight into action. #MPNResearch
Why do some people develop #MPNs, while others never do? What we know so far comes from years of research.  Progress depends on funding science.  Your support makes research possible.  Invest in research: https://f.mtr.cool/bilbrgbjdf
What defines meaningful progress in MPN research? Clinical endpoints and perspectives that shape them. At #MPNRoundtable, researchers, clinicians, industry partners, and patients convened to align on how progress is measured. Patient-informed science moves the field forward.
From one early grant supporting the MPN-RC to a global research consortium.  This is the ripple effect of funding collaboration and infrastructure.  Last chance — there is still time to give. Invest in research: https://f.mtr.cool/qegnjxucfd #MPN #CancerResearch @mpn_consortium
Grateful to @UChicago for welcoming us into the Drazer Group & HIM labs during the 2026 #MPNRoundtable. Early-stage research shows where progress in MPNs begins and how it moves forward through collaboration. Join us in moving research forward: https://f.mtr.cool/sqzvnrbvmg
Scientific presentations don’t have to feel inaccessible.  Join us for MPN Pathways: Empowered Voices in Research: Patients' & Caregivers’ Guide to Scientific Presentations. Register today: https://f.mtr.cool/ynqailytir #MPNPathways #MPNVoices #PatientEducation #RareDisease
Feeling overwhelmed by scientific slides or abstracts?  Join us next week for our new MPN Pathways webinar with Amielle Moreno, PhD and Tyler Parsons, PhD to learn more.  June 18 | 5 – 6pm CT  Virtual  Register: https://f.mtr.cool/koixymtunj #MPNPathways #ResearchEducation
6d
13d
21d
25d
27d
28d
23d
18d
26d
11d
Video
The MPN PROGRESSion Registry™ is a patient-focused research initiative that collects comprehensive, long-term, myeloproliferative neoplasm (MPN) patient health data.
f.mtr.cool
MPN PROGRESSion Registry™ – MPN Research Foundation